Summary
Ethanol (2.4 g/kg) was given intraperitoneally to mice and was found to cause a marked increase in spontaneous locomotor activity. When mice were pretreated with low doses of agents which mimic or augment the action of GABA (γ-hydroxybutyric acid, baclophen, or aminooxyacetic acid) the ethanol-induced locomotor stimulation was completely eliminated. Baclophen (10 mg/kg) was found to cause an initial increase followed by a later decrease in synthesis of catecholamines, as measured by the accumulation of dopa after inhibition of central aromatic l-amino acid decarboxylase, in dopamine-rich areas of rat brain. These data are consistent with previous findings that baclophen, as well as other agents which enhance the activity of GABA systems, reduce the firing of dopamine neurons, thus causing enhanced synthesis of dopamine via feedback mechanisms. These findings also indicate a potential interaction between GABA-like drugs and alcohol in man, and may be of heuristic value in the treatment of chronic alcoholism. The possibility that the mechanism of the inhibition of ethanol-induced locomotor stimulation by GABA-like drugs may be due to a selective interference with ethanol-induced dopamine release is discussed.
Similar content being viewed by others
References
Aghajanian, G. K., Roth, R. H.: γ-Hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy. J. Pharmacol. exp. Ther. 175, 131–138 (1970)
Ahlenius, S., Brown, R., Engel, J., Svensson, T. H., Waldeck, B.: Antagonism by nialamide of the ethanol-induced locomotor stimulation in mice. J. Neural Transmission 35, 175–178 (1974)
Ahlenius, S., Carlsson, A., Engel, J., Svensson, T. H., Södersten, P.: Antagonism by alpha methyltyrosine of the ethanol-induced stimulation and euphoria in man. Clin. Pharmacol. Ther. 14, 586–591 (1973)
Andén, N.-E.: Inhibition of the turnover of the brain dopamine after treatment with the gammaaminobutyrate: 2-oxyglutarate transaminase inhibitor aminooxyacetic acid. Naunyn-Schmiedeberg's Arch. Pharmacol. 283, 419–424 (1974)
Andén, N.-E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantio nigra. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 89–92 (1973)
Andén, N.-E., Wachtel, H.: Biochemical effects of baclofen (β-parachlorophenyl-GABA) on the dopamine and noradrenaline in the rat brain. Acta pharmacol. (Kbh.) (in press, 1976)
Atack, C., Lindqvist, M.: Conjoint native and orthophthaldialde-hydecondensate assays for the fluorimetric determination of 5-hydroxyindoles in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 267–284 (1973)
Bédard, P., Carlsson, A., Lindqvist, M.: Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Phyrmacol. 272, 1–15 (1972)
Carlsson, A.: Some aspects of dopamine in the central nervous system. In: Advances in Neurology, Vol. 5, pp. 59–68. New York: Raven Press 1974
Carlsson, A.: Receptor-mediated control of dopamine metabolism. In Pre- and postsynaptic receptors (E. Usdin and W. E. Bunney, Jr., eds.), pp. 49–65. New York: Marcel Dekker Inc. 1975a
Carlsson, A.: Dopaminergic autoreceptors. In: Chemical tools in catecholamine research, Vol. II (O. Almgren, A. Carlsson, and J. Engel, eds.), pp. 219–225. Amsterdam: North-Holland Pub. Co. 1975b
Carlsson, A.: Pharmacological approach to schizophrenia. In: Schizophrenia: biological and physiological perspectives (G. Usdin, ed.), pp. 102–124. New York: Brunner/Mazel Pub. 1975c
Carlsson, A., Lindqvist, M.: Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. J. Pharm. Pharmacol. 25, 437–440 (1973)
Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C. V.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 153–168 (1972a)
Carlsson, A., Engel, J., Svensson, T. H.: Inhibition of ethanol-induced excitation in mice and rats by α-methyl-p-tyrosine. Psychopharmacologia (Berl.) 26, 307–312 (1972b)
Carlsson, A., Magnusson, T., Svensson, T. H., Waldeck, B.: Effect of ethanol on the metabolism of brain catecholamines. Psychopharmacologia (Berl.) 30, 27–36 (1973)
Carlsson, A., Kehr, W., Lindqvist, M.: The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain. J. Neural Transmission (in press, 1976)
Corrodi, H., Fuxe, K., Hökfelt, T.: The effect of ethanol on the activity of the catecholamine neurons in the rat brain. J. Pharm. Pharmacol. 18, 821–823 (1966)
Cott, J. M.: Investigations into the mechanism of reduction of ethanol-induced sleep by thyrotropin-releasing hormone (TRH). Ph. D. thesis, Department of Pharmacology, University of North Carolina at Chapel Hill, 1975
Curtis, D. R., Game, C. J. A., Johnston, G. A. R., McCulloch, R. M.: Central effects of β-(p-chlorophenyl)-γ-aminobutyric acid. Brain Res. 70, 493–499 (1974)
Davies, J., Watkins, J. C.: The action of β-phenyl-GABA derivatives on neurones of the cat cerebral cortex. Brain Res. 70, 501–505 (1974)
Dray, A., Straughan, D. W.: Synaptic mechanisms in the substantia nigra. J. Pharm. Pharmacol. 28, 400–405 (1976)
Engel, J., Carlsson, A.: Catecholamines and behavior. In: Current developments in psychopharmacology (L. Valzelli and W. B. Essman, eds.), vol. 4. New York: Spectrum Pub. Inc. (in press, 1976)
Engel, J., Strömbom, U., Svensson, T. H., Waldeck, B.: Suppression by α-methyltyrosine of the ethanol-induced locomotor stimulation: partial reversal by l-dopa. Psychopharmacologia (Berl.) 37, 275–279 (1974)
Fuxe, K., Agnati, L. F., Hökfelt, T., Jonsson, G., Lidbrink, P., Ljungdahl, Å.: The effect of dopamine receptor stimulating and blocking agents on the activity of supersensitive dopamine receptors and on the amine turnover in various dopamine nerve terminal systems in the rat brain. J. Pharmacol. 6, 117–129 (1975a)
Fuxe, K., Hökfelt, T., Ljungdahl, Å., Agnati, L., Johansson, O., Perez de la Mora, M.: Evidence for an inhibitory gabergic control of the mesolimbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs. Med. Biol. 53, 177–183 (1975b)
Gessa, G. L., Vargiu, L., Crabai, F., Boero, G. C., Caboni, F., Camba, R.: Selective increase of brain dopamine induced by gamma-hydroxybutyrate. Life Sci. 5, 1921–1930 (1966)
Goldstein, D. B.: Alcohol withdrawal reactions in mice: effects of drugs that modify neurotransmission. J. Pharmacol. exp. Ther. 186, 1–9 (1973)
Hornykiewicz, O., Lloyd, K. G., Davidson, L.: The GABA system, function of the basal ganglia, and Parkinson's disease. In: GABA in nervous system function (E. Roberts, T. N. Chase, and O. B. Tower, eds.), pp. 479–485. New York: Raven Press 1976
Hunt, W. A., Majchrowicz, E.: Alterations in the turnover of brain norepinephrine and dopamine in alcohol-dependent rat. J. Neurochem. 23, 549–552 (1974)
Hutchins, D. A., Rayevsky, K. S., Sharman, D. F.: The effect of sodium-γ-hydroxybutyrate on the metabolism of dopamine in the brain. Brit. J. Pharmacol. 46, 409–415 (1972)
Kehr, W., Carlsson, A., Lindqvist, M.: A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 273–280 (1972a)
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., Atack, S.: Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J. Pharm. Pharmacol. 24, 744–747 (1972b)
Pohorecky, L. A., Jaffe, L. S.: Noradrenergic involvement in the acute effects of ethanol. Res. Commun. Chem. Path. Pharmacol. 12, 433–445 (1975)
Read, G. W., Cutting, W., Furst, A.: Comparison of excited phases after sedatives and tranquilizers. Psychopharmacologia (Berl.) 1, 346–350 (1960)
Roberts, E.: A model of the vertebrate nervous system based largely on disinhibition: a key role of the GABA system. In: Neurohumoral coding of brain function (R. D. Myers, ed.), pp. 419–449 New York: Plenum Press 1974
Roth, R. H.: Formation and regional distribution of γ-hydroxybutyric acid in mammalian brain. Biochem. Pharmacol. 19, 3013–3019 (1970)
Roth, R. H., Suhr, Y.: Mechanism of the γ-hydroxybutyrate-induced increase in brain dopamine and its relationship to “sleep”. Biochem. Pharmacol. 19, 3001–3012 (1970)
Roth, R. H., Walters, J. R., Aghajanian, G. K.: Effect of impulse flow on the release and synthesis of dopamine in the rat striatum. In: Frontiers of catecholamine research (E. Usdin and S. Snyder, eds.), pp. 567–574. New York: Pergamon 1973
Roth, R. H., Walters, J. R., Morgenroth, V. H., III: Effects of alterations in impulse flow on transmitter metabolism in central dopaminergic neurons. In: Neuropsychopharmacology of monoamines and their regulatory enzymes (E. Usdin, ed.), pp. 369–384. New York: Raven Press 1974
Stevens, J., Wilson, K., Foote, W.: GABA blockade, dopamine and schizophrenia: experimental studies in the cat. Psychopharmacologia (Berl.) 39, 105–119 (1974)
Stock, G., Magnusson, T., Andén, N.-E.: Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 347–361 (1973)
Sutton, I., Simmonds, M. A.: Effects of acute and chronic ethanol on the γ-aminobutyric acid system in rat brain. Biochem. Pharmacol. 22, 1685–1692 (1973)
Svensson, T. H., Waldeck, B.: Significance of acetaldehyde in ethanol-induced effects on catecholamine metabolism and motor activity in the mouse. Psychopharmacologia (Berl.) 31, 229–238 (1973)
Sytinsky, I. A., Guzikov, B. M., Gomanko, M. V., Eremin, V. P., Konovalova, N. N.: The gammaaminobutyric acid (GABA) system in brain during acute and chronic ethanol intoxication. J. Neurochem. 25, 43–48 (1975)
Waalkes, T. P., Udenfriend, S.: A fluorimetric method for the estimation of tyrosine in plasma and tissues. J. Lab. clin. Med. 50, 733–736 (1957)
Waldeck, B.: Ethanol and caffeine: a complex interaction with respect to locomotor activity and central catecholamines. Psychopharmacologia (Berl.) 36, 209–220 (1974)
Wallach, D. P.: Studies on the GABA pathway. I. The inhibition of γ-aminobutyric acid-α-ketoglutaric acid transminase in vitro and in vivo by U-7524 (aminooxyacetic acid). Biochem. Pharmacol. 323–331 (1961)
Weiss, B., Laties, B. G.: Effects of amphetamine, chlorpromazine, pentobarbitol, and ethanol on operant response duration. J. Pharmacol. exp. Ther. 144, 17–23 (1964)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cott, J., Carlsson, A., Engel, J. et al. Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naunyn-Schmiedeberg's Arch. Pharmacol. 295, 203–209 (1976). https://doi.org/10.1007/BF00505087
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00505087